Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
DexCom, Inc. - Common Stock
(NQ:
DXCM
)
68.48
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about DexCom, Inc. - Common Stock
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
22 Stocks Moving in Friday's Pre-Market Session
April 30, 2021
Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 30.7% to $6.00 in pre-market trading after the company announced it initiated a quarterly dividend of $0.12 per share,...
Via
Benzinga
Dexcom Inc (DXCM) Q1 2021 Earnings Call Transcript
April 29, 2021
DXCM earnings call for the period ending March 31, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
15 Stocks Moving In Thursday's After-Hours Session
April 29, 2021
Gainers Amazon (NASDAQ: AMZN) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above...
Via
Benzinga
Recap: DexCom Q1 Earnings
April 29, 2021
Shares of DexCom (NASDAQ:DXCM) fell in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were down 25.00% over the past year to...
Via
Benzinga
Dexcom Beats First-Quarter Expectations, But Shares Tumble
April 29, 2021
Dexcom stock tumbled late Thursday after the diabetes devices company reported adjusted earnings of 33 cents per share on $505 million in sales.
Via
Investor's Business Daily
Dexcom Reports First Quarter 2021 Financial Results
April 29, 2021
From
DexCom, Inc.
Via
Business Wire
3 Unstoppable Growth Stocks You Can Hold for Decades
April 21, 2021
Each proved its worth during the coronavirus pandemic.
Via
The Motley Fool
Exposures
COVID-19
Senseonics Stock Will Likely Rise on the Same Trajectory As DexCom
April 09, 2021
Senseonics will rise on the same trajectory as DexCom. SENS stock could rise 5 to 10 times over the next 5 years with FDA approval.
Via
InvestorPlace
Exposures
Product Safety
The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
April 29, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...
Via
Benzinga
The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx
April 24, 2021
Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For April 15, 2021
April 15, 2021
Upgrades According to JP Morgan, the prior rating for Vipshop Holdings Ltd (NYSE:VIPS) was changed from Neutral to Overweight. In the fourth quarter, Vipshop Holdings...
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.